Plasma and urinary suPAR levels among secondary FSGS patients with different degrees of effacement of foot processes. a There was no significant difference in plasma suPAR levels in the segmental-effacement and diffuse-effacement groups (3,306 [2,901–4,479] vs. 3,827.7 [2,522.8–4,516] pg/mL, p = 0.76). b There was also no significant difference in urinary suPAR levels in the segmental-effacement and diffuse-effacement groups (352 [258–561] vs. 393 [196–513] pg/μmoL, p = 0.89).